Trial Search Results
Electrical Stimulation as an Adjunctive Therapy to Increase Vascular Perfusion in People With PAD or PVD
The purpose of this study is to apply Avazzia micro-current stimulation to patients with chronic, non-healing wounds to determine if this therapy is effective in perfusion and bacterial measurements.
Stanford is currently accepting patients for this trial.
- Device: Tennant Biomodulator-Pro™ Device
- Patient has a chronic non-healing wound that has not healed in 30 days in their feet,
legs, lower back or buttocks, but not in their hands because the hands will be used to
verify equipment operation.
- Age ≥18 and ≤70 years
- Wound area is ≥0.5 cm2 and ≤22 cm2
- Willing and able to comply with weekly visits to clinic (e.g., reliable
- Presence of an electrical implant such as a cardiac pacemaker or neural stimulator
- Patient is currently pregnant, possibly pregnant or breast-feeding User of any
microcurrent device in the past six (6) months prior to enrollment in the study
- Patient is experiencing a medical emergency
- Patient is diagnosed with neuropathy from sources other than diabetes, such as heavy
metal, xenobiotic toxicity
- Patient is diagnosed with Charcot-Marie-Tooth or similar genetically inheritable
- Patient is diagnosed with end-stage kidney disease/dialysis or severe kidney
- Patient is diagnosed with malignancies (cancers) undergoing treatment
Ages Eligible for Study
18 Years - 70 Years
Genders Eligible for Study